RecruitingNCT07502677

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis


Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Enrollment

15 participants

Start Date

Mar 24, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The specific aim of this study is to try to discover the diagnostic accuracy of SleepImage technology for detecting respiratory failure in patients with MND. Importantly, this research project is not about NIV, it is about what method can most efficiently decide when to start NIV. To do this we'd like to collect data about you and your breathing from the SleepImage device when you come in for your routine overnight sleep study. We will compare this against the data that we would collect anyway.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients aged 18 and over with a Neurologist confirmed diagnosis of ALS

Exclusion Criteria4

  • Patients with known respiratory disease
  • Unstable cardiac disease, stable hypertension or ischaemic heart disease
  • Current NIV use
  • Inability to give consent (expected \~15% due to frontotemporal dementia)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESleepImage

SleepImage Device


Locations(1)

Royal Brompton Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07502677


Related Trials